The longevity platform your clinic can put its own name on.
Two white-label tiers, scaled by partner volume, delivered under Voué Swiss Services — and applicable to whichever product branch(es) a practice carries.
The outer carton is the surface a practice makes its own. The sachet inside stays consistent — the same fixed formula per line, produced on the same platform, verified by the same laboratories.
Clinics have no credible supplement partner today.
Three options exist, and each one fails the practice in a different way.
Mass-market vitamins
Cheap, and with no clinical credibility to stand behind.
DTC beauty gummies
Consumer-marketed, and sold outside the clinic relationship entirely.
Pharmacy-grade actives
Credible, but generic — with no positioning for your channel.
The result: clinics leave revenue on the table, and patients buy generic supplements elsewhere — taking their loyalty with them. Voué's answer is BASE, GLOW, HAIR and BALANCE positioned as the add-on to treatments patients already pay for, sold through the clinic rather than around it.
Your consultation room is already a distribution moment.
of physicians say a patient bought a supplement because they recommended it.
say most or nearly all patients follow their guidance.
Sermo Physician Survey, 374 physicians, 2026, via Nutraceuticals World.
Four categories, one combined opportunity.
Voué sits where the supplement, medical-aesthetic, hair and menopause markets overlap — together, $57.5B moving toward $86.5B.
| Market | 2026 | Projected | CAGR | Source |
|---|---|---|---|---|
| European supplements | $25.6B | $38.1B | 8.2% to 2031 | Mordor Intelligence |
| European medical aesthetics | $4.66B | $8.64B | 11.0% to 2031 | MarketsandMarkets |
| European hair-loss treatment | $0.84B | $1.19B | 7.0% to 2030 | Mordor Intelligence |
| European menopause | $26.4B | $38.6B | 4.9% to 2033 | MarketDataForecast |
| Combined | $57.5B | $86.5B |
These are market-level estimates for category-scale context, not a revenue forecast for any individual clinic.
Two white-label tiers, scaled by volume.
Both tiers include onboarding, patient education material, and access to the Education pillar — so the commercial relationship starts with the product and grows into a full practice-building partnership.
| What is being compared | Tier 1Standard Label | Tier 2Full Co-Brand |
|---|---|---|
| Outer packaging | Partner-branded | Partner-branded |
| Inner sachet | Standard silver, black product name | Partner-branded sachet |
| Positioning | Generic silver and black, practice-branded outside | Fully co-branded system, practice + Voué Swiss |
| Volume | Lower minimum order | Higher-volume commitment, per line |
| Best for | Practices starting their home-care offer | Established or multi-site practices building a proprietary retail line |
Pricing, margin structures, packaging lead times and technical/laboratory documentation are shared under NDA once access is approved — nothing on this page constitutes a binding offer or public price list.
Built by people who already know this market.
15+ years inside the medical-aesthetic market
The founding team has worked directly with aesthetic and hair-restoration clinics across Europe for over 15 years.
Nutrition & nutraceutical formulation expertise
Deep, hands-on formulation expertise sits inside the founding team — developed with category knowledge, not outsourced to a manufacturer.
Exclusive manufacturing & distribution rights
Production runs with Epicode GmbH, inventors of SphiroX®, with distribution exclusivity for the medical-aesthetic channel — a moat competitors cannot replicate.
A supplement line built around trust you've already earned.
Sell it as Voué and you can be live from next day. Go fully private-label and typical lead time is 8–10 weeks, signed contract to first delivery, while your own packaging is produced.